Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Seagen, Delta Air Lines And 2 Other Stocks Insiders Are Selling

Published 01/03/2023, 14:05
Updated 01/03/2023, 15:10
© Reuters.  Seagen, Delta Air Lines And 2 Other Stocks Insiders Are Selling
GRMN
-
ETR
-
DAL
-
DEAI34
-
E1TR34
-
G1RM34
-

Benzinga - The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Delta Air Lines

  • The Trade: Delta Air Lines, Inc. (NYSE: DAL) President Glen W Hauenstein sold a total of 5,000 shares at an average price of $37.87. The insider received around $189.32 thousand from selling those shares.
  • What’s Happening: Kyndryl entered into 5-year extended agreement with Delta Air Lines to enhance IT resiliency & scalability.
  • What Delta Air Lines Does: Delta Air Lines Inc is airlines, with a network of over 300 destinations in more than 50 countries.

Seagen

  • The Trade: Seagen Inc. (NASDAQ: SGEN) CFO Todd E Simpson sold a total of 20,000 shares at an average price of $182.53. The insider received around $3.65 million from selling those shares.
  • What’s Happening: According to a Wall Street Journal report citing people familiar with the matter, Pfizer is in early stage talks to acquire Seagen.
  • What Seagen Does: Seagen (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Garmin

  • The Trade: Garmin Ltd. (NASDAQ: GRMN) EVP, Operations Patrick Desbois sold a total of 6,165 shares at an average price of $98.43. The insider received around $606.82 thousand from selling those shares.
  • What’s Happening: Garmin reported a fourth-quarter FY22 revenue decline of 6% year-on-year to $1.31 billion, beating the consensus of $1.30 billion.
  • What Garmin Does: Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine.

Entergy

  • The Trade: Entergy Corporation (NYSE: ETR) EVP and General Counsel Marcus V Brown sold a total of 12,500 shares at an average price of $106.10. The insider received around $1.33 million from selling those shares.
  • What’s Happening: Entergy posted in-line earnings for the fourth quarter.
  • What Entergy Does: Entergy is a holding company with five regulated integrated utilities that generate and distribute electricity to about 3 million customers in Arkansas, Louisiana, Mississippi, and Texas.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.